Navigation Links
Endocare Reports 2008 First Quarter Financial Results
Date:5/1/2008

adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, and also excluding non-cash stock compensation expense, collectively "adjusted EBITDA") has no basis in GAAP. The Company's management believes that this non-GAAP financial measure provides useful information to investors, permitting a better evaluation of the Company's ongoing and underlying business performance, including the evaluation of its performance against its competitors in the healthcare industry. Management uses this non-GAAP financial measure for purposes of its internal projections and to evaluate the Company's financial performance.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies. A complete reconciliation of this non-GAAP financial measure for the applicable periods to the most directly comparable GAAP measures is presented in an accompanying table.

About Endocare

Endocare, Inc. -- http://www.endocare.com -- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing cryoablation (freezing) technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).

Statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties. Among the important factors that could cause actual results to differ materially from those in the forward-looking statements include,
'/>"/>

SOURCE Endocare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
2. LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
3. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
4. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
5. Alexion Reports First Quarter 2008 Results
6. Masimo Reports First Quarter 2008 Financial Results
7. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
8. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
9. SuperGen Reports 2008 First Quarter Financial Results
10. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
11. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... NORTH BRUNSWICK, New Jersey , ... Pharmaceuticals, société de découverte médicamenteuse spécialisée ... d,agents antibiotiques destinés à soigner les ... annoncé aujourd,hui la présentation de données ... clinique majeur, le TXA709, dans la ...
(Date:4/27/2015)... HEIDELBERG , Germany ... Addresses unmet need in treatment of millions of cancer ... been granted a patent in Europe ... supports Molecular Health,s discovery that EPHB4 is a novel receptor ... tumor growth. EPO stimulates the production of red blood cells ...
(Date:4/27/2015)... April 27, 2015  Together with its customers, Elekta ... Forum in Barcelona . The funds ... with the mission to improve cancer care, specifically radiation ... believes that no patient should be denied potentially life-saving ... it cooperates with hospitals and clinics around the world ...
(Date:4/24/2015)... April 24, 2015 Leading Regenerative ... in its allogeneic stem-cell product development program and ... reflect the corporate strategic direction. , “I am ... adipose stem cell development program has been kicked ... cGMP manufacturing facility and hiring of our new ...
Breaking Biology Technology:TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 2TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 3TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 4TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 5TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 6Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology 2Elekta helps raise $33,000 to bring radiation treatment to developing countries 2Elekta helps raise $33,000 to bring radiation treatment to developing countries 3Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2
... to maneuver separately without any obvious guidance are now ... led by a Duke University computer scientist. , "It,s ... at this fine a resolution with such very, very ... computer science and biochemistry. , Each microrobot is shaped ...
... DIEGO, June 2 Amylin Pharmaceuticals,Inc. (Nasdaq: ... present new data,for its FDA-approved diabetes drugs, BYETTA(R) ... pipeline diabetes and,obesity drug candidates at the American ... in San Francisco, CA from June 6 to,10. ...
... , CALL DATE: Tuesday, June 3, 2008, ... HOST: Dr. Candace Kendle, Chairman ... telephone conference call and,simultaneous webcast on Tuesday, June 3 at 9:30 ... that,was announced on May 30 and to provide an update on ...
Cached Biology Technology:Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/20/2015)... April 20, 2015 The announcement ... Glenbeigh Records Management (GRM), Ireland,s ... Islamic Bank. Having built up an impressive track record of ... leading player within the records management sector in ... double is GCC staffbase and employ a further eight staff ...
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... different species manage to coexist. If two species ... will be more efficient and out-compete the other. ... evolved morphological or physiological traits that allow it ... other species. Such partitioning of resources essentially provides ...
... Great Barrier Reef released by the CSIRO shows for the ... travel to the outer reef, and beyond. , The ... year, challenge conventional thought that sediment travelling from our river ... and travels no more than 10 to 15km offshore, affecting ...
... chess, the reason may be in your genes. , ... University School of Medicine in St. Louis, has gathered the ... signaling pathways in the brain influences one kind of intelligence. ... performance IQ, which involves a person's ability to organize things ...
Cached Biology News:Virtual duck bills demonstrate species coexistence 2CSIRO imagery shows Outer Great Barrier Reef at risk from river plumes 2Genes and genius: Researchers confirm association between gene and intelligence 2Genes and genius: Researchers confirm association between gene and intelligence 3
The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....
4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI)...
... This depletion cocktail is ... cells from suspensions of rat ... using the StemSep (or compatible ... system. The T cell content ...
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
Biology Products: